OrthoPediatrics (KIDS) Stock Analysis & Winston Score
OrthoPediatrics makes medical devices specifically designed for children who need bone and joint surgery. Its products include surgical implants, braces, and instruments used to treat conditions like scoliosis, broken bones, and limb deformities in kids. The company focuses almost entirely on pediatric orthopedics, which is a narrow but underserved niche — most adult orthopedic devices do not fit children's smaller bodies. The company sells its products to hospitals and pediatric orthopedic surgeons, primarily in the United States but also in international markets. It generates revenue mainly through direct sales of implants and instruments, often using a loaner kit model where sets of tools are placed with hospitals. With a gross margin near 74%, the underlying product economics are solid, but the company is not yet profitable at the operating level. The key growth driver is expanding its product portfolio and international reach, while the main risk is that its small size makes it vulnerable to competition from larger medical device companies entering the pediatric space.
Winston Score: 33/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (10/30)
- Growth: Mixed (6/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $25.65
Market Cap: $659M
Sector: Healthcare
Industry: Medical - Devices
Exchange: NASDAQ
